Prostate Cancer - Results from #25480

Patient management, and time and health care resource utilization associated with the use of intravenous bisphosphonates for patients with metastatic bone disease: A Delphi study - Abstract July 11, 2012

Incidental finding of parathyroid adenoma with 11C-choline PET/CT - Abstract July 11, 2012

Patient positioning variations to reduce dose to normal tissues during 3D conformal radiotherapy for high-risk prostate cancer - Abstract July 11, 2012

Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer: A validation study on an Italian patient population undergoing first and repeat biopsy - Abstract July 10, 2012

Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study - Abstract July 10, 2012

Greater percent-free testosterone is associated with high-grade prostate cancer in men undergoing prostate biopsy - Abstract July 10, 2012

Decision preparation, satisfaction and regret in a multi-center sample of men with newly diagnosed localized prostate cancer - Abstract July 10, 2012

Health-related quality of life for men with prostate cancer-an evaluation of outcomes 12-24 months after treatment - Abstract July 10, 2012

Editor's Commentary - Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial July 10, 2012

Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial - Abstract July 10, 2012

ASTRO responds to CMS proposal that reduces reimbursement rates for IMRT, SBRT July 10, 2012

Robotic-assisted radical prostatectomy in men less than or equal to 50 years of age. Surgical, oncological and functional outcomes - Abstract July 10, 2012

MicroRNAs as putative mediators of treatment response in prostate cancer - Abstract July 10, 2012

Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality - Abstract July 10, 2012

Does primary androgen-deprivation therapy delay the receipt of secondary cancer therapy for localized prostate cancer? - Abstract July 9, 2012

The role of IMiDs alone or in combination in prostate cancer - Abstract July 9, 2012

Urine colour after radical prostatectomy predicts urinary leakage at the vesicourethral anastomosis - Abstract July 9, 2012

The prostate cancer conundrum revisited : Treatment changes and prostate cancer mortality declines - Abstract July 9, 2012

Current status of transrectal ultrasound techniques in prostate cancer - Abstract July 9, 2012

Sipuleucel-T for the treatment of advanced prostate cancer - Abstract July 9, 2012

Page 1275 of 1438